Ondansetron

NDC 51655-913 · Northwind Health Company, LLC

Generic nameOndansetron

Dosage formTABLET, ORALLY DISINTEGRATING

RouteORAL

Active ingredient(s)ONDANSETRON

Strength4 mg/1

Pharmacologic classSerotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

51655-913-20 — 20 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-20)

51655-913-53 — 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-53)

51655-913-54 — 15 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-54)

FDA lists these products with the same active ingredient.

50090-1128 — Ondansetron, 50090-1200 — Ondansetron, 50090-1201 — Ondansetron, 50090-1658 — Ondansetron, 50090-1659 — Ondansetron, 50090-2343 — Ondansetron, 50090-4632 — Ondansetron, 51655-008 — Ondansetron, 51655-196 — Ondansetron, 51655-809 — Ondansetron, 51662-1246 — ONDANSETRON, 51662-1514 — ONDANSETRON, 55154-3680 — Ondansetron, 55154-4567 — ondansetron, 55154-8339 — Ondansetron, 57237-077 — Ondansetron, 57237-078 — Ondansetron, 60760-306 — Ondansetron, 60760-654 — Ondansetron, 60760-936 — Ondansetron, +78 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.